The world has a shortage of organs suitable for human transplantation. In the US alone, as of March 2020 there were over 112,000 men, women, and children on the national transplant waiting list.
What if scientists could 3D-print new organs with a patients' own cells, eliminating the need for donated organs and the risk of rejection when organs are transplanted? That's exactly the path Cellink is pursuing: producing bioink and bioprinting technologies to enable researchers to 3D-print organs and tissue for applications that span industries, from pharmaceutical to cosmetic.
In 2016, CELLINK commercialized the world’s first bioink, a biomaterial innovation eight years in the making. That milestone was the first of many along the company’s journey to become the world’s leading bioprinting company; they currently have systems to optimize cell-based applications for more than 1,000 scientists across more than 55 countries.
CELLINK was the first company to provide a standardized bio-ink product for sale over the internet. Researchers leverage its technologies to print liver, cartilage, skin tissues and more.
GOAL 3: Good Health and well-being
Cellink ensures healthy lives and promotes well-being for all at every age.
But what if scientists could 3D-Print new organs with a patients' own celles, eliminating te need for donated organs and the risk of rejection? That's exactly the path Cellink is pursuing, producing bioink and bioprinting technologies to advance the field.
The 3DEXPEIENCE platform enables Cellink to better predict and understand how living material will behave once it is bioprinted. The team can identify problems and virtually develop fixes before bioprinting an actual structure. By optimizing this process, Cellink can help academia and pharmaceutical companies efficiently bioprint organs and to test drugs in a unique, organ-like environment to accelerate research.
Studies estimate the annual number of deaths due to medical errors in the hundreds of thousands, so there is great incentive to revise the way the medical profession gains knowledge and experience. Advances in 3D printing technology and virtual simulation are creating new opportunities to improve the quality of treatments and patient safety.
Have you been in a situation where a generic treatment did not work very well for you or someone you know? Have you ever had that nagging feeling that maybe the doctor (as good as he or she may be) should really be treating YOU rather than a generalized representation of you?
One in 160 children has an autism spectrum disorder according to the United Nations. Children with autism have learning and developmental disorders, and represent a number higher than all others disabilities put together. In the US alone, over 6.4% children have special needs in terms of cognitive, motor and sensory processing skills.
Inaccurate medications kill five times more people than road accidents do in developed countries. In France alone, this costs 10 billion euros to the public health system.
The Living Heart Project aims to advance the development of safe and effective cardiovascular products and treatments by uniting engineering, scientific, and biomedical expertise to translate cutting-edge science into improved patient care. Through simulation and the creation of validated models, the project aims to provide personalized, interventional patient care.
Two 3D experiences, ultra realistic on a scientific point of view, were created through collaborative projects with technologic and scientific partners: "Staying Alive" and "Born To Be Alive".
"Staying Alive" is a serious game that allows to learn appropriate behaviors for first aid techniques.
For patients with chronic illnesses, a primary goal is to create the best possible quality of life for living with a disease. During diagnosis or clinical trials , recording data from patients is often done over a too short a period of time for a proper clinical conclusion.
Do you think your project is the next big thing?
Join the team !